The only lipid metabolite that was significantly elevated in the stroke patient serums vs. the controls was ether phosphatidylcholine (PC-O [42:4]) (Figure 2 and Figure 3; VIP > 2, Figure 1b). The gene discussed is VIP; the disease is stroke disorder.